View in EDS

Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer Types.

Saved in:
Bibliographic Details
Title: Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer Types.
Authors: Topham JT; Pancreas Centre BC, Vancouver, British Columbia, Canada., Titmuss E; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Pleasance ED; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Williamson LM; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Karasinska JM; Pancreas Centre BC, Vancouver, British Columbia, Canada., Culibrk L; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Lee MKC; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., Mendis S; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., Denroche RE; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Jang GH; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Kalloger SE; Pancreas Centre BC, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Wong HL; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., Moore RA; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., O'Kane GM; University Health Network, University of Toronto, Toronto, Ontario, Canada., Knox JJ; University Health Network, University of Toronto, Toronto, Ontario, Canada., Gallinger S; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; University Health Network, University of Toronto, Toronto, Ontario, Canada., Loree JM; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., Mager DL; Terry Fox Laboratory, BC Cancer, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Laskin J; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada., Marra MA; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Jones SJM; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Schaeffer DF; Pancreas Centre BC, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada., Renouf DJ; Pancreas Centre BC, Vancouver, British Columbia, Canada. drenouf@bccancer.bc.ca.; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Sep; Vol. 19 (9), pp. 1889-1897. Date of Electronic Publication: 2020 Jun 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32518206
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer Types.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Topham+JT%22">Topham JT</searchLink>; Pancreas Centre BC, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Titmuss+E%22">Titmuss E</searchLink>; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Pleasance+ED%22">Pleasance ED</searchLink>; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Williamson+LM%22">Williamson LM</searchLink>; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Karasinska+JM%22">Karasinska JM</searchLink>; Pancreas Centre BC, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Culibrk+L%22">Culibrk L</searchLink>; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Lee+MKC%22">Lee MKC</searchLink>; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Mendis+S%22">Mendis S</searchLink>; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Denroche+RE%22">Denroche RE</searchLink>; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Jang+GH%22">Jang GH</searchLink>; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Kalloger+SE%22">Kalloger SE</searchLink>; Pancreas Centre BC, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Wong+HL%22">Wong HL</searchLink>; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Moore+RA%22">Moore RA</searchLink>; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Mungall+AJ%22">Mungall AJ</searchLink>; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22O'Kane+GM%22">O'Kane GM</searchLink>; University Health Network, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Knox+JJ%22">Knox JJ</searchLink>; University Health Network, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Gallinger+S%22">Gallinger S</searchLink>; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; University Health Network, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Loree+JM%22">Loree JM</searchLink>; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Mager+DL%22">Mager DL</searchLink>; Terry Fox Laboratory, BC Cancer, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Laskin+J%22">Laskin J</searchLink>; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Marra+MA%22">Marra MA</searchLink>; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Jones+SJM%22">Jones SJM</searchLink>; Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Schaeffer+DF%22">Schaeffer DF</searchLink>; Pancreas Centre BC, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Renouf+DJ%22">Renouf DJ</searchLink>; Pancreas Centre BC, Vancouver, British Columbia, Canada. drenouf@bccancer.bc.ca.; Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2020 Sep; Vol. 19 (9), pp. 1889-1897. <i>Date of Electronic Publication: </i>2020 Jun 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32518206
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-20-0094
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1889
    Titles:
      – TitleFull: Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer Types.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Topham JT
      – PersonEntity:
          Name:
            NameFull: Titmuss E
      – PersonEntity:
          Name:
            NameFull: Pleasance ED
      – PersonEntity:
          Name:
            NameFull: Williamson LM
      – PersonEntity:
          Name:
            NameFull: Karasinska JM
      – PersonEntity:
          Name:
            NameFull: Culibrk L
      – PersonEntity:
          Name:
            NameFull: Lee MKC
      – PersonEntity:
          Name:
            NameFull: Mendis S
      – PersonEntity:
          Name:
            NameFull: Denroche RE
      – PersonEntity:
          Name:
            NameFull: Jang GH
      – PersonEntity:
          Name:
            NameFull: Kalloger SE
      – PersonEntity:
          Name:
            NameFull: Wong HL
      – PersonEntity:
          Name:
            NameFull: Moore RA
      – PersonEntity:
          Name:
            NameFull: Mungall AJ
      – PersonEntity:
          Name:
            NameFull: O'Kane GM
      – PersonEntity:
          Name:
            NameFull: Knox JJ
      – PersonEntity:
          Name:
            NameFull: Gallinger S
      – PersonEntity:
          Name:
            NameFull: Loree JM
      – PersonEntity:
          Name:
            NameFull: Mager DL
      – PersonEntity:
          Name:
            NameFull: Laskin J
      – PersonEntity:
          Name:
            NameFull: Marra MA
      – PersonEntity:
          Name:
            NameFull: Jones SJM
      – PersonEntity:
          Name:
            NameFull: Schaeffer DF
      – PersonEntity:
          Name:
            NameFull: Renouf DJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2020 Sep
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1